.jpg)
ZhongAn Online P&C Insurance Co. and US-based biotechnology company Orig3n, Inc. have partnered to bring health technology to Chinese consumers.
Through the partnership, online-only insurer ZhongAn will supplement its insurance offerings with healthcare solutions including a suite of DNA tests, aimed at its customer base of nearly 500 million people, and to the China market as a whole. The product suite will be backed by Orig3n’s extensive knowledge of genetic testing applications, being one of the leading direct-to-consumer DNA test platforms in the US.
The two companies will establish a new laboratory in Shanghai, focused on development and application of healthcare technologies. According to ZhongAn, locating the lab in Shanghai will enable the companies to provide Chinese consumers with personalised, efficient, and convenient healthcare solutions.
“We had been looking to complement ZhongAn’s product suite with health tech solutions to meet evolving consumer demands and identified Orig3n as the ideal partner due to its technology and industry-leading mobile platform,” said Liu Haijiao, president of life sciences at ZhongAn. “We look forward to partnering with Orig3n to provide innovative new products for our customers and the broader China market.”
Robin Smith, CEO of Orig3n, added: “We are very excited to have ZhongAn as a strategic partner in China. “With our strong knowledge base and IP and ZhongAn’s brand awareness and extensive reach with consumers, we are confident that together we will make a significant impact in the PRC.”
